Aimei Health Technology Co., Ltd (AFJK)
Aimei Health Technology Co., Ltd operates in the Shell Companies industry of the Financial Services sector, headquartered in New York City, NY, US. The stock last traded at $12.08, up 0.58% on the session, giving a market capitalisation of $38.2M. On trailing twelve-month figures it carries a trailing P/E of 72.08, a net margin of 0.0%. Its beta of 0.55 implies it has historically moved less than the broad market.
Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.
Aimei Health Technology Co., Ltd is most often compared with the following Financial Services names: